Erinmcasey

In Area under the curve, can you add an example of the use of AUC in trials, such as in dose selection for carcinogenicity studies of pharmaceuticals per ICH S1C(R2)?

November 2013

Hello, I'm BracketBot. I have automatically detected that your edit to Clinical Dementia Rating may have broken the syntax by modifying 1 "[]"s. If you have, don't worry: just edit the page again to fix it. If I misunderstood what happened, or if you have any questions, you can leave a message on my operator's talk page.

List of unpaired brackets remaining on the page:

• <ref> http://europepmc.org/abstract/MED/10811551/reload=0;jsessionid=J4SIwN8HlWM1LV4p72WP.56]</ref>. Thus the CDR appears to be a reliable and valid tool for assessing and staging dementia.

Thanks, BracketBot (talk) 22:46, 25 November 2013 (UTC)

It is really nice that you could use some of our notes from earlier in the semester on Pharmacokinetics and AUC as presented by Dr. McNamara. I am sure you could find many research papers on the topic as well to give examples. — Preceding unsigned comment added by Sabode2 (talk • contribs) 19:04, 3 December 2013 (UTC)